Aterectomia rotacional na era dos drug-eluting stents. O ressurgimento duma técnica esquecida?

Drug Eluting Stents; A new era in Interventional Cardiology

INTRODUCTION Over the last decade or so, no other subspecialty of medicine has seen such technological innovations, as interventional cardiology. These advances have revolutionized the management of coronary artery disease. From statin drugs to oral platelets inhibitors like clopidogrel and ticlopidine, intravenous platelet glycoprotein IIb/IIIa receptor blockers like Abciximab (Reo-Pro), Eptif...

Drug-eluting stents: new era and new concerns.

At present there is much excitement about drug-eluting stents, which hold promise for the treatment of coronary artery disease. This ingenious therapy involves coating the outside of a standard coronary stent with a thin polymer containing medication that can prevent scarring at the site of coronary intervention. Early trials with sirolimus coated stents showed that they might prevent coronary ...

Rotational atherectomy in the era of drug-eluting stents.

Atherosclerosis is one of the most significant underlying problems that can affect patients with cardiovascular disease. In the most serious situations, this condition affects blood supply to the heart or brain, resulting in heart attack, stroke, or sudden cardiac death. In 1977, Andreas Gruentzig performed the first percutaneous transluminal coronary angioplasty (PTCA), a less invasive method ...

Drug-eluting stents.

New Drug-Eluting Stents

The introduction of drug-eluting stents (DES) has rapidly and profoundly affected the field of interventional cardiology, and DESs are now used in a majority of intracoronary stenting procedures. As a result of the innumerable “trial-and-error” endeavors, DESs have emerged as a potential solution for solving the problem of restenosis. DESs are coated stents capable of releasing single or multip...